BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25417880)

  • 1. [DNA methylation-mediated epigenetic silencing of miR-720 contributes to leukemogenesis in acute myeloid leukemia].
    Tang S; Pei R; Li K; Ma J; Zhang P; Lu Y; Liu X; DU X; Chen D; Sha K; Cao J; Li S
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):1009-12. PubMed ID: 25417880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
    Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
    Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferation, migration and apoptosis of acute myeloid leukemia cells regulated by mir-23a-3p targeting SMC1A and the mechanism].
    Zhang YS; Wang MY; Zhang WL; Tang CH
    Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):753-759. PubMed ID: 31648497
    [No Abstract]   [Full Text] [Related]  

  • 6. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
    Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
    BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role of epigenetic inactivation of miR-9 in EVI1
    Mittal N; Li L; Sheng Y; Hu C; Li F; Zhu T; Qiao X; Qian Z
    Mol Cancer; 2019 Feb; 18(1):30. PubMed ID: 30813931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
    Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0104700 contributes to acute myeloid leukemia progression by enhancing MCM2 expression through targeting miR-665.
    Chen K; Ning X; Yan X; Song L
    Hematology; 2023 Dec; 28(1):2227489. PubMed ID: 37358551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-212-5p regulates the proliferation and apoptosis of AML cells through targeting FZD5.
    Lin JF; Zeng H; Zhao JQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8415-8422. PubMed ID: 30556883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia.
    Wang XX; Zhang H; Li Y
    Mol Med Rep; 2019 Apr; 19(4):2943-2952. PubMed ID: 30720097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
    Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis.
    Wang Z; Luo H; Fang Z; Fan Y; Liu X; Zhang Y; Rui S; Chen Y; Hong L; Gao J; Zhang M
    BMB Rep; 2018 Sep; 51(9):444-449. PubMed ID: 29764561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2'-deoxycytidine by targeting miR-9.
    Li F; He W; Geng R; Xie X
    Clin Transl Oncol; 2020 Jan; 22(1):137-143. PubMed ID: 31054042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy.
    Deng R; Shen N; Yang Y; Yu H; Xu S; Yang YW; Liu S; Meguellati K; Yan F
    Biomaterials; 2018 Jun; 167():80-90. PubMed ID: 29554483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
    Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
    J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.